Filing Details
- Accession Number:
- 0001127602-24-003352
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-05 16:01:30
- Reporting Period:
- 2024-02-02
- Accepted Time:
- 2024-02-05 16:01:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1916310 | Jacobus Johannes Oosthuizen | Merck &Amp; Co., Inc. 126 East Lincoln Avenue Rahway NJ 07065 | President, U.s. Market | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-02 | 6,773 | $75.36 | 28,122 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-02 | 7,045 | $73.73 | 35,167 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-02 | 7,119 | $87.10 | 42,286 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-02 | 18,959 | $127.18 | 23,327 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-02 | 6,773 | $0.00 | 6,773 | $75.36 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-02 | 7,045 | $0.00 | 7,045 | $73.73 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-02-02 | 7,119 | $0.00 | 7,119 | $87.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-05-01 | 2030-04-30 | No | 4 | M | Direct |
| 7,049 | 2022-05-04 | 2031-05-03 | No | 4 | M | Direct |
| 14,240 | 2023-05-03 | 2032-05-02 | No | 4 | M | Direct |
Footnotes
- Holdings include shares acquired in dividend reinvestment transactions.
- The option vested and became exercisable in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
- The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
- The option vests and becomes exercisable in three equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
Billionaire Hedge Funds
